Andra AP-fonden’s Edwards Lifesciences EW Stock Holding History

Andra AP-fonden’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.21M	Buy	114,969 +84,969	+283%	+$7.01M	0.11%	213
2025 Q4	$2.56M	Sell	30,000 -50,600	-63%	-$4.15M	0.03%	343
2025 Q3	$6.27M	Buy	80,600 +79,400	+6,617%	+$6.2M	0.08%	253
2025 Q2	$93.9K	Sell	1,200 -129,900	-99%	-$9.69M	﹤0.01%	449
2025 Q1	$9.5M	Buy	131,100 +76,800	+141%	+$5.5M	0.16%	218
2024 Q4	$4.02M	Sell	54,300 -84,400	-61%	-$5.91M	0.06%	303
2024 Q3	$9.15M	Buy	138,700 +54,900	+66%	+$3.99M	0.13%	233
2024 Q2	$7.74M	Buy	83,800 +46,700	+126%	+$4.14M	0.13%	239
2024 Q1	$3.55M	Buy	+37,100	New	+$3.12M	0.06%	300
2023 Q3	–	Sell	-84,200	Closed	-$7.94M	–	368
2023 Q2	$7.94M	Sell	84,200 -9,600	-10%	-$834K	0.2%	196
2023 Q1	$7.76M	Sell	93,800 -34,500	-27%	-$2.71M	0.2%	209
2022 Q4	$9.57M	Buy	128,300 +13,300	+12%	+$1.03M	0.29%	70
2022 Q3	$9.5M	Buy	115,000 +14,700	+15%	+$1.41M	0.31%	66
2022 Q2	$9.54M	Buy	+100,300	New	+$10.4M	0.27%	94
2021 Q4	$13.1M	Buy	101,100 +7,000	+7%	+$817K	0.27%	112
2021 Q3	$10.7M	Sell	94,100 -2,400	-2%	-$274K	0.22%	163
2021 Q2	$9.99M	Buy	+96,500	New	+$9.1M	0.2%	196
2021 Q1	–	Sell	-102,600	Closed	-$9.36M	–	590
2020 Q4	$9.36M	Buy	102,600 +19,900	+24%	+$1.65M	0.21%	180
2020 Q3	$6.6M	Sell	82,700 -16,800	-17%	-$1.31M	0.18%	248
2020 Q2	$6.88M	Buy	99,500 +12,200	+14%	+$867K	0.2%	154
2020 Q1	$5.49M	Sell	87,300 -15,000	-15%	-$1.08M	0.2%	129
2019 Q4	$7.96M	Sell	102,300 -1,800	-2%	-$141K	0.23%	58
2019 Q3	$7.63M	Buy	104,100 +3,900	+4%	+$274K	0.23%	68
2019 Q2	$6.17M	Sell	100,200 -18,900	-16%	-$1.14M	0.18%	231
2019 Q1	$7.6M	Buy	+119,100	New	+$6.8M	0.22%	98
2018 Q3	$7.71M	Buy	132,900 +600	+0.5%	+$29.3K	0.2%	177
2018 Q2	$6.42M	Sell	132,300 -16,500	-11%	-$770K	0.17%	249
2018 Q1	$6.92M	Buy	148,800 +112,500	+310%	+$4.89M	0.18%	215
2017 Q4	$1.36M	Buy	36,300 +6,000	+20%	+$220K	0.03%	629
2017 Q3	$1.1M	Sell	30,300 -4,200	-12%	-$160K	0.03%	635
2017 Q2	$1.36M	Sell	34,500 -36,300	-51%	-$1.32M	0.03%	598
2017 Q1	$2.22K	Sell	70,800 -13,200	-16%	-$413K	0.05%	476
2016 Q4	$2.62M	Sell	84,000 -15,000	-15%	-$486K	0.07%	440
2016 Q3	$3.98M	Sell	99,000 -15,900	-14%	-$599K	0.11%	300
2016 Q2	$3.82M	Buy	114,900 +18,600	+19%	+$636K	0.1%	312
2016 Q1	$2.83M	Sell	96,300 -23,100	-19%	-$637K	0.07%	412
2015 Q4	$3.14M	Sell	119,400 -64,200	-35%	-$1.67M	0.09%	343
2015 Q3	$4.35M	Sell	183,600 -22,200	-11%	-$536K	0.13%	233
2015 Q2	$4.88M	Sell	205,800 -3,000	-1%	-$67.7K	0.14%	214
2015 Q1	$4.96M	Sell	208,800 -109,800	-34%	-$2.46M	0.14%	213
2014 Q4	$6.76M	Buy	318,600 +33,000	+12%	+$663K	0.16%	209
2014 Q3	$4.86M	Sell	285,600 -9,600	-3%	-$152K	0.11%	273
2014 Q2	$4.22M	Buy	295,200 +253,200	+603%	+$3.43M	0.09%	326
2014 Q1	$519K	Sell	42,000 -96,600	-70%	-$1.11M	0.01%	527
2013 Q4	$1.52M	Buy	138,600 +79,800	+136%	+$900K	0.04%	462
2013 Q3	$682K	Sell	58,800 -99,600	-63%	-$1.17M	0.02%	522
2013 Q2	$1.77M	Buy	+158,400	New	+$1.87M	0.05%	443

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Andra AP-fonden's EW Position: Q1 2026 in Review

Andra AP-fonden increased its Edwards Lifesciences (EW) stake by 283% in Q1 2026, buying an estimated $7.01M and bringing the position to 114,969 shares worth $9.21M. The position accounts for 0.11% of the portfolio, ranked #213.

Andra AP-fonden first reported a position in EW in Q2 2013 and has held it in 47 quarters since. The position peaked at $13.1M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Andra AP-fonden held 114,969 shares of Edwards Lifesciences worth $9.21M as of Q1 2026.
Andra AP-fonden bought 84,969 Edwards Lifesciences shares in Q1 2026, an estimated $7.01M.
Edwards Lifesciences made up 0.11% of Andra AP-fonden's portfolio in Q1 2026, its #213 holding.
Andra AP-fonden first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 47 quarters since.
Andra AP-fonden's Edwards Lifesciences position peaked at $13.1M in Q4 2021.
1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.